Related Experiment Videos
Alfred Hospital Coronary Care Unit: an acute myocardial infarction quality assurance study
1Department of Cardiology, Alfred Hospital, Prahran, Victoria, Australia.
Insights
Thrombolytic therapy improved outcomes for acute myocardial infarction patients, with faster treatment times and increased interventions like coronary angiography and PTCA. This study highlights the benefits of timely thrombolysis in improving patient care pathways.
Area of Science:
- Cardiology
- Emergency Medicine
- Clinical Trials
Background:
- Acute myocardial infarction (AMI) is a leading cause of mortality.
- Timely reperfusion therapy, including thrombolysis, is crucial for improving outcomes in AMI patients.
- Assessing the efficacy and delivery of thrombolytic therapy in a real-world setting is essential.
Purpose of the Study:
- To evaluate the effectiveness of thrombolytic therapy in patients with acute myocardial infarction.
- To analyze patient characteristics and treatment timelines, from symptom onset to hospital admission and therapy administration.
- To compare outcomes between patients receiving thrombolytic therapy and those who did not.
Main Methods:
- A six-month prospective study involving 120 patients admitted with AMI to a coronary care unit.
- Data collection included patient demographics, time intervals (chest pain to ED, ED to thrombolysis, ED to CCU), interventions, and outcomes.
- Statistical analysis compared outcomes between thrombolytic and non-thrombolytic groups.
Main Results:
- 50% of AMI patients received thrombolytic therapy, predominantly Streptokinase (97%), with 80% administered in the Emergency Department.
- Thrombolytic group patients were younger, presented earlier, and received faster transfer to the coronary care unit compared to the non-thrombolytic group.
- The thrombolytic group showed higher rates of coronary angiography and percutaneous transluminal coronary angioplasty (PTCA), with no significant differences in mortality or length of stay.
Conclusions:
- Early administration of thrombolytic therapy in acute myocardial infarction is associated with improved patient presentation and transfer times.
- Thrombolytic therapy facilitates timely interventions such as coronary angiography and PTCA.
- While not impacting mortality in this study, timely thrombolysis is a key component of acute myocardial infarction management.
Abstract:
A six-month prospective study was performed to assess the efficacy of delivering thrombolytic therapy to patients with acute myocardial infarction and admitted to the coronary care unit. Patient characteristics, time from chest pain onset to presentation to emergency department, from presentation to thrombolytic therapy, transfer from emergency department to coronary care unit major interventions and outcome were assessed. One hundred and twenty patients were admitted with acute myocardial infarction, mean age 66 years (26-91), 69% were males. Of these, 50% received thrombolytic therapy. The mean time from chest pain onset to emergency department was 192 +/- 164 minutes, transfer from emergency department to coronary care unit was 195 +/- 150 minutes. The mean time from presentation to emergency department to receiving thrombolytics was 63 +/- 12 minutes. Streptokinase was the choice of thrombolytic in 97%. Thrombolytic therapy was administered in emergency department in 80% of cases. Thirty-eight (63%) patients received thrombolytic therapy within 60 minutes of presentation. Compared to the non-thrombolytic group, the thrombolytic group were younger, 63 vs 69 years, P < 0.01, presented earlier to hospital (192 vs 394 minutes, P < 0.0005), were transferred to coronary care unit sooner (195 vs 472 minutes, P < 0.001), and had more coronary angiograms (29 vs 23, P < 0.02) and PTCA performed 10 vs 3, P < 0.04. There were no significant differences in length of coronary care unit stay, length of hospital stay, patients receiving CABG or death.